{"name":"Rhizen Pharmaceuticals SA","slug":"rhizen-pharmaceuticals-sa","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"RP12146","genericName":"RP12146","slug":"rp12146","indication":"Other","status":"phase_1"},{"name":"RP6530","genericName":"RP6530","slug":"rp6530","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"RP12146","genericName":"RP12146","slug":"rp12146","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"RP6530","genericName":"RP6530","slug":"rp6530","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijAJBVV95cUxOT3V0UTc3SUE5NDZKYmcxR292V2pYcVhMWjlfaGRfZlpqYTlQYzhRd3RoNXI3N3doZU5ReEVoZmI4RUlBYkM2VWJwNnFWc2xwajk0eWp4RWJvWnZVS1NrRlJuOHlVX1BxQmZPWXMwWFRKWjBpU240ajlrUzNpcWpwR05RMUtycGNUMHZmOHRMWEtNS1NxLUxmNXJxWnlPREhkbThuS0RSSU15cWM5ZUJUam0zd3ZhOGJVaTB3TDl2WTlBMHFKNzZ1NDFpaXNUYzM2LWgtcUl4VHNNbm8yWVc1SVZTT1ota2ZJb3RZVGphY0hOR2FsZ1R5MWs4NVk3MEVYd1dWMk8xSEIwRUZJ?oc=5","date":"2025-04-24","type":"pipeline","source":"PR Newswire","summary":"IBRANCE's Market Growth Marks a Significant Step Forward in Metastatic HR+/HER2− Breast Cancer Treatment Landscape | DelveInsight - PR Newswire","headline":"IBRANCE's Market Growth Marks a Significant Step Forward in Metastatic HR+/HER2− Breast Cancer Treatment Landscape | Del","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwJBVV95cUxNbDVNY2Vtekhac0k0RU5Rc0hGN3FTVFA2UTRaMlRvbnduYW54TEtEUFpmdjIzYWUxQ1k1Rmt4R3JtVEtPTkFQMWRhTmxtOEctdGJMN0RCSlJ2dWxsWWRkN0xucC1ETkxZSnhEX0JEeGZVTXpTMjZSeDJwbWphbGRQa3lNTEFkTG5XOUZDZ1ZSa0JXWFlUbGFhRDZ0M29QSlIxQUg1Rk8wMXlUUEFEWG5CQndyS0tDQVp2T2tmM0lzeTZRSEtIbk1DVzY3ZWVpX0RZcWJ6MWtSS0FJd21JTTNwVXcxeHpBSXJlVHl3MmIxMUtlQWVLaVlfTVhvWUdobkRiVDFTM0pkWTFYSHo4RjN3TU1VYUV5dk1XZjRya3ptcUwwREpUamVveE9QYU4zSUxSU3djOWZNTQ?oc=5","date":"2024-10-01","type":"trial","source":"GlobeNewswire","summary":"Breast Cancer Clinical Trial Pipeline Appears Robust With - GlobeNewswire","headline":"Breast Cancer Clinical Trial Pipeline Appears Robust With","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxNZ1R2OG0yX293dnl5YVhwS3UtcmtBQ0wzaFFFMVZBcVA0TmFZQnFJUXNKYjBNVEJoMkE1dlFjcXRVRTNhSk8tLUgzZjl3MkJMZFJIOTV4QzdhVWJMUmtqZXQwai1QLXVqNk50cUF4TkJtaDlUOHdkaUFtM3Ixak4tYm5JRjl5VHVJaHloSFFYN25RTkM5S2NvOWlIT250bDA5MEloU2phQm5TZklCdEFzQ2c3ZGdfWHF0eThURTMyOW1LSXRzVGpOaENhWFBzVHNyRzlEamp1RU96bW5vZWc0?oc=5","date":"2024-09-25","type":"pipeline","source":"PR Newswire","summary":"CDK 7 Inhibitors Market is Expected to Showcase a Significant Growth by 2034 | DelveInsight - PR Newswire","headline":"CDK 7 Inhibitors Market is Expected to Showcase a Significant Growth by 2034 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE5rdVBmWUptN3F5UXBHWXhnMlBkNVlWem4xU2o0SWp3eGZXVkl0M1hDTXFscWJ5MlFoZllQZU1Bemx5cEs1UTJ0bkVwbzE0MGp2VVFtRzJsSmZMQnFXMkk2SktDNVYwRGtEMmZSM1JmOXFweFVkYXRncmxOUQ?oc=5","date":"2022-09-10","type":"regulatory","source":"Straits Research","summary":"Multiple Myeloma Therapeutics Market Size, Demand, Forecast to 2033 - Straits Research","headline":"Multiple Myeloma Therapeutics Market Size, Demand, Forecast to 2033","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2020-12-03","type":"regulatory","source":"Medical Dialogues","summary":"Alembic Pharma associate firm gets USFDA nod for trial on retroviral oral drug for COVID treatment - Medical Dialogues","headline":"Alembic Pharma associate firm gets USFDA nod for trial on retroviral oral drug for COVID treatment","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2020-10-13","type":"pipeline","source":"Moneycontrol.com","summary":"Alembic Pharma share price gains as associate company enters agreement to develop Tenalisib - Moneycontrol.com","headline":"Alembic Pharma share price gains as associate company enters agreement to develop Tenalisib","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2020-10-12","type":"pipeline","source":"GlobeNewswire","summary":"Rhizen Pharmaceuticals S.A. and Curon Biopharmaceutical Limited Announce an Exclusive Licensing Agreement to Develop and Commercialize Tenalisib, a Dual PI3K Delta and Gamma Inhibitor for Oncology in ","headline":"Rhizen Pharmaceuticals S.A. and Curon Biopharmaceutical Limited Announce an Exclusive Licensing Agreement to Develop and","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxOZ0pub01MZHZvTHdxZGtpdkwxRV9GQ3JWRXBjMm1KQThNS3RWaUJwck9WLVp0RWd6Q2d6NlNmV2t0bEZOeC1CZ1hadlN0Z3RzekVEZU45RHkyVVpIR3h4NnZoWlhmWEc1WXcxUG1xekNlNmFJRzNQb1FoSzdkUUtwRmQxTUZkdmtCYVBva3JuVjQ2R2vSAZgBQVVfeXFMTWZOZW10cmx1bDhMMGRrWHpDQ0RmNW9MdzRhM1VrQUJmWmpWeW1mc3FUOXFiUndXaG5KNzBPb2dtVXgzUDc5WVpsZWpzUFZ3a1NhWGZjR0NFd19zUnByN1FTdjQ4ZXBUSVZOQ201WTBoLW1jYmZib1hXRFpsZUlVZmwtQkZvRXgyLTBKMVRDaksyZFNZWmxmaDc?oc=5","date":"2015-12-11","type":"pipeline","source":"Medical Dialogues","summary":"Alembic Pharma arm ties up with Novartis for drug development - Medical Dialogues","headline":"Alembic Pharma arm ties up with Novartis for drug development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxObFFXUVhOUjR0dDgyZ2gyaTlRZEo0TV9kdU9sU1phd0FEbUhLVDJERXNLOGdKbElDa0lFUklPUjdrUzBHZ3NfNUV5cFlENmZxS2FjNmxBZGpkY3hSMEN0MGZ6RHNXU3ZfMDN3c3ByRVZ5R0NFVVBTRFpIY1pnVUItbUtETTNEVy02OVAtbDhxSUswVFBQYjhrY2pFRVRuNU5aZDNTVFI4YzhYUndqZzRCTTRxbXo?oc=5","date":"2015-12-10","type":"earnings","source":"NDTV Profit","summary":"Alembic Pharma Arm Ties Up With Novartis for Drug Development - NDTV Profit","headline":"Alembic Pharma Arm Ties Up With Novartis for Drug Development","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":2},"enrichmentLevel":2,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}